{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T11:04:14Z","timestamp":1756897454276},"reference-count":128,"publisher":"Informa UK Limited","issue":"4","funder":[{"name":"no funding"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Anti-infective Therapy"],"published-print":{"date-parts":[[2024,4,2]]},"DOI":"10.1080\/14787210.2024.2334054","type":"journal-article","created":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T16:19:22Z","timestamp":1711124362000},"page":"153-167","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Challenges, risks, and opportunities of antiretroviral drugs in women of reproductive potential"],"prefix":"10.1080","volume":"22","author":[{"given":"Alexis C.","family":"Henderson","sequence":"first","affiliation":[{"name":"Division of HIV Prevention, National Center for HIV, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Preetam","family":"Cholli","sequence":"additional","affiliation":[{"name":"Division of HIV Prevention, National Center for HIV, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret A.","family":"Lampe","sequence":"additional","affiliation":[{"name":"Division of HIV Prevention, National Center for HIV, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athena P.","family":"Kourtis","sequence":"additional","affiliation":[{"name":"Division of HIV Prevention, National Center for HIV, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2024,3,27]]},"reference":[{"key":"e_1_3_5_2_1","unstructured":"World Health Organization. HIV data and statistics. World Health Organization; Jul 2023. Available from: https:\/\/www.who.int\/teams\/global-hiv-hepatitis-and-stis-programmes\/hiv\/strategic-information\/hiv-data-and-statistics"},{"volume-title":"The path that ends AIDS: uNAIDS global AIDS update 2023","year":"2023","key":"e_1_3_5_3_1","unstructured":"The path that ends AIDS: uNAIDS global AIDS update 2023. Geneva: Joint United Nations Programme on HIV\/AIDS; 2023. Licence: CC BY-NC-SA 3.0 IGO."},{"issue":"1","key":"e_1_3_5_4_1","article-title":"Estimated HIV incidence and prevalence in the United States, 2015\u20132019","volume":"26","author":"Center for Disease Control and Prevention","year":"2021","unstructured":"Center for Disease Control and Prevention. Estimated HIV incidence and prevalence in the United States, 2015\u20132019. HIV Surv Supple Rep. 2021;26(1).","journal-title":"HIV Surv Supple Rep"},{"issue":"49","key":"e_1_3_5_5_1","first-page":"665","article-title":"Unexplained immunodeficiency and opportunistic infections in infants\u2013New York, New Jersey, California","volume":"31","author":"Centers for Disease Control","year":"1982","unstructured":"Centers for Disease Control. Unexplained immunodeficiency and opportunistic infections in infants\u2013New York, New Jersey, California. MMWR Morb Mortal Wkly Rep. 1982 Dec 17;31(49):665\u2013667.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.6.531"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03530120044039"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3181b9869f"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199411033311801"},{"volume-title":"Joint United Nations programme on HIV\/AIDS and the United States President\u2019s emergency plan for AIDS Relief","year":"2019","key":"e_1_3_5_10_1","unstructured":"Joint United Nations programme on HIV\/AIDS and the United States President\u2019s emergency plan for AIDS Relief. Start Free Stay Free AIDS Free framework; 2019."},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2022-059604"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0b013e3283636ccb"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0223536"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcl.2021.08.007"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12577"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.81a.14009"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32835521a3"},{"key":"e_1_3_5_18_1","volume-title":"Recommendations for the use of antiretroviral drugs during pregnancy and interventions to reduce perinatal HIV transmission in the United States","author":"Panel on Treatment of HIV During Pregnancy and Prevention of Perinatal Transmission","year":"2023","unstructured":"Panel on Treatment of HIV During Pregnancy and Prevention of Perinatal Transmission. Recommendations for the use of antiretroviral drugs during pregnancy and interventions to reduce perinatal HIV transmission in the United States. Department of Health and Human Services; 2023 [cited 2023 Oct]."},{"key":"e_1_3_5_19_1","volume-title":"Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. 2nd ed. Geneva: World Health Organization; 2016.","edition":"2"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.6.531"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)80008-7"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.270.5238.899"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506816"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1600693"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001612"},{"key":"e_1_3_5_27_1","volume-title":"Guidelines for the use of antiretroviral agents in adults and adolescents with HIV","author":"Panel on Antiretroviral Guidelines for Adults and Adolescents","year":"2023","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. Department of Health and Human Services; 2023 [cited 2023 Oct]."},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1507198"},{"key":"e_1_3_5_29_1","volume-title":"Guideline: updates on HIV and infant feeding: the duration of breastfeeding, and support from health services to improve feeding practices among mothers living with HIV","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. Guideline: updates on HIV and infant feeding: the duration of breastfeeding, and support from health services to improve feeding practices among mothers living with HIV. Geneva Switzerland: World Health Organization; 2016."},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1202614"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pctr.0020027"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402269"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1110711"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1108524"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000000172"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00538-4"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003670"},{"key":"e_1_3_5_39_1","unstructured":"Centers for Disease Control and Prevention. PrEP for HIV prevention in the U.S. 2023 Sep 29. Available from: https:\/\/www.cdc.gov\/nchhstp\/newsroom\/fact-sheets\/hiv\/PrEP-for-hiv-prevention-in-the-US-factsheet.html"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmedr.2022.102062"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijregi.2023.01.004"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2055-6640(20)30312-5"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(20)30106-5"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1872"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S248696"},{"key":"e_1_3_5_46_1","volume-title":"Conference on Retroviruses and Opportunistic Infections (CROI)","author":"Delany-Moretlwe S","year":"2022","unstructured":"Delany-Moretlwe S, Hughes J, Guo X, et al. Evaluation of CAB-LA safety and PK in pregnant women in the blinded phase of HPTN 084. Conference on Retroviruses and Opportunistic Infections (CROI); Virtual 2022."},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25426"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.8735"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000000413"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001867"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001850"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25378"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000003312"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001861"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506110"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002690"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000003494"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2017.0201"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001762"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(19)30335-2"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000000880"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.3851\/IMP2647"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.14130"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-018-3087-8"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0108150"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-019-2419-z"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1186\/s43058-022-00331-0"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000002597"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.3851\/IMP2638"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz121"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1550-8579(07)80025-8"},{"key":"e_1_3_5_73_1","volume-title":"Pregnant women: scientific and ethical considerations for inclusion in clinical trials guidance for industry","author":"FDA","year":"2018","unstructured":"FDA. Pregnant women: scientific and ethical considerations for inclusion in clinical trials guidance for industry. Rockville (MD): U.S. Department of Health and Human Services Food and Drug Administration; Center for Drug Evaluation and Research (CDER); Center for Biologics Evaluation and Research (CBER); 2018."},{"key":"e_1_3_5_74_1","unstructured":"IMPAACT P1026S\/PK in pregnancy: pharmacokinetic properties of antiretroviral and related drugs during pregnancy and postpartum [Internet]. 2020. Available from: https:\/\/www.impaactnetwork.org\/studies\/p1026s."},{"key":"e_1_3_5_75_1","unstructured":"IMPAACT 2026: pharmacokinetic properties of antiretroviral and anti-tuberculosis drugs during pregnancy and postpartum [Internet]. 2021. Available from: https:\/\/www.impaactnetwork.org\/studies\/impaact2026."},{"key":"e_1_3_5_76_1","unstructured":"The PHASES Working Group. Ending the evidence gap for pregnant women around HIV & co-infections: a call to action [internet]. Chapel Hill (NC): 2020 [cited Feb 2024]. Available from: http:\/\/hiv.pregnancyethics.org."},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-020-00897-9"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-020-00977-w"},{"key":"e_1_3_5_79_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2200600"},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-012-0002-0"},{"key":"e_1_3_5_81_1","doi-asserted-by":"publisher","DOI":"10.3851\/IMP3341"},{"key":"e_1_3_5_82_1","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12252"},{"key":"e_1_3_5_83_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-020-00914-x"},{"key":"e_1_3_5_84_1","unstructured":"Guttmacher Institute. Contraceptive use in the United States by method - fact sheet. 2021 May."},{"key":"e_1_3_5_85_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001392"},{"key":"e_1_3_5_86_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6914a3"},{"key":"e_1_3_5_87_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6503a1"},{"key":"e_1_3_5_88_1","doi-asserted-by":"publisher","DOI":"10.1111\/aji.12210"},{"key":"e_1_3_5_89_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-016-0452-7"},{"key":"e_1_3_5_90_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ1001"},{"key":"e_1_3_5_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(19)30155-9"},{"key":"e_1_3_5_92_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006250-200606000-00055"},{"key":"e_1_3_5_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2023.109951"},{"key":"e_1_3_5_94_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2324"},{"key":"e_1_3_5_95_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-007-0020-y"},{"key":"e_1_3_5_96_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1807653"},{"key":"e_1_3_5_97_1","volume-title":"Potential safety issue affecting women living with HIV using dolutegravir at the time of conception","author":"Statement on DTG","year":"2018","unstructured":"Statement on DTG. Potential safety issue affecting women living with HIV using dolutegravir at the time of conception. Geneva: World Health Organization; 2018. Internet."},{"key":"e_1_3_5_98_1","article-title":"Update on neural tube defects with antiretroviral exposure in the tsepamo study, Botswana","author":"Zash R","year":"2022","unstructured":"Zash R, Holmes LB, Diseko M, et al. Update on neural tube defects with antiretroviral exposure in the tsepamo study, Botswana. AIDS. 2022.","journal-title":"AIDS"},{"key":"e_1_3_5_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(20)30268-X"},{"key":"e_1_3_5_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(23)00108-X"},{"key":"e_1_3_5_101_1","doi-asserted-by":"publisher","DOI":"10.3389\/frph.2023.1221101"},{"key":"e_1_3_5_102_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0284893"},{"key":"e_1_3_5_103_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.971"},{"key":"e_1_3_5_104_1","volume-title":"Antiretroviral pregnancy registry interim report for 1 January 1989 through 31 January 2023","author":"Antiretroviral Pregnancy Registry Steering Committee","year":"2023","unstructured":"Antiretroviral Pregnancy Registry Steering Committee. Antiretroviral pregnancy registry interim report for 1 January 1989 through 31 January 2023. Morrisville (NC): Registry Coordinating Center; 2023."},{"key":"e_1_3_5_105_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00199"},{"key":"e_1_3_5_106_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)90063-3"},{"key":"e_1_3_5_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00314-7"},{"key":"e_1_3_5_108_1","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25922"},{"key":"e_1_3_5_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61809-7"},{"key":"e_1_3_5_110_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-018-0201-6"},{"key":"e_1_3_5_111_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000002152"},{"key":"e_1_3_5_112_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4121"},{"key":"e_1_3_5_113_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0246272"},{"key":"e_1_3_5_114_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2212877"},{"issue":"1","key":"e_1_3_5_115_1","first-page":"6","article-title":"Pregnancy outcomes in pregnant women with HIV on tenofovir disoproxil fumarate (TDF) compared to tenofovir alafenamide (TAF)","volume":"4","author":"Thimm MA","year":"2022","unstructured":"Thimm MA, Livingston A, Ramroop R, et al. Pregnancy outcomes in pregnant women with HIV on tenofovir disoproxil fumarate (TDF) compared to tenofovir alafenamide (TAF). J AIDS HIV Treat. 2022;4(1):6\u201313.","journal-title":"J AIDS HIV Treat"},{"key":"e_1_3_5_116_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001277"},{"key":"e_1_3_5_117_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000003020"},{"key":"e_1_3_5_118_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001963"},{"key":"e_1_3_5_119_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000001424"},{"key":"e_1_3_5_120_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000000686"},{"key":"e_1_3_5_121_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2019.05.015"},{"key":"e_1_3_5_122_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab203"},{"key":"e_1_3_5_123_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2019.05.034"},{"key":"e_1_3_5_124_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy471"},{"key":"e_1_3_5_125_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001359"},{"key":"e_1_3_5_126_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000003215"},{"key":"e_1_3_5_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101368"},{"key":"e_1_3_5_128_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir307"},{"key":"e_1_3_5_129_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002593"},{"key":"e_1_3_5_130_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000000281"},{"key":"e_1_3_5_131_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001770"},{"key":"e_1_3_5_132_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002824"}],"container-title":["Expert Review of Anti-infective Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14787210.2024.2334054","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T02:26:00Z","timestamp":1727231160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14787210.2024.2334054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,27]]},"references-count":128,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4,2]]}},"alternative-id":["10.1080\/14787210.2024.2334054"],"URL":"https:\/\/doi.org\/10.1080\/14787210.2024.2334054","relation":{},"ISSN":["1478-7210","1744-8336"],"issn-type":[{"type":"print","value":"1478-7210"},{"type":"electronic","value":"1744-8336"}],"subject":[],"published":{"date-parts":[[2024,3,27]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierz20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierz20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-12-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}